Alpha 2.0
Login Register
» Articles » PMID: 33798462

Can Glucose-lowering Drugs Affect the Prognosis of COVID-19 in Patients with Type 2 Diabetes?

Overview
Journal Lancet Diabetes Endocrinol
Specialty Endocrinology
Date 2021 Apr 2
PMID 33798462
Citations 4
Authors
Guntram Schernthaner
Affiliations
Soon will be listed here.
Citing Articles

Repurposing Metformin for Vascular Disease.

Triggle C, Marei I, Ye K, Ding H, Anderson T, Hollenberg M Curr Med Chem. 2022; 30(35):3955-3978.

PMID: 35909294 PMC: 10286558. DOI: 10.2174/0929867329666220729154615.

The management of type 2 diabetes before, during and after Covid-19 infection: what is the evidence?.

Czupryniak L, Dicker D, Lehmann R, Prazny M, Schernthaner G Cardiovasc Diabetol. 2021; 20(1):198.

PMID: 34598700 PMC: 8485772. DOI: 10.1186/s12933-021-01389-1.

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9).

Schernthaner G Diabetes Metab J. 2021; 45(4):615-616.

PMID: 34352990 PMC: 8369206. DOI: 10.4093/dmj.2021.0081.

Anti-inflammatory effects of GLP-1 in patients with COVID-19.

Sazgarnejad S, Yazdanpanah N, Rezaei N Expert Rev Anti Infect Ther. 2021; 20(3):373-381.

PMID: 34348067 PMC: 8425436. DOI: 10.1080/14787210.2021.1964955.